Linear accelerator selection: Impact on feasibility dose-volume histograms and practicality in dose reduction for organs at risk during prostate volumetric-modulated arc therapy
These findings highlight that the choice of the linear accelerator significantly impacts OAR dose reduction. In prostate VMAT, TrueBeam demonstrated superior rectal and bladder dose reduction compared to Halcyon, underscoring the importance of selecting the appropriate device to optimize treatment planning and minimize variability.
Authors
- Yuji Nakaguchi (ORCID: https://orcid.org/0000-0002-1016-9921)
- Masataka Oita (ORCID: https://orcid.org/0000-0002-8667-6209)
- Hitoshi Ikushima (ORCID: https://orcid.org/0000-0003-1578-4293)
- Motoharu Sasaki (ORCID: https://orcid.org/0000-0002-9561-0287)
- Takeshi Kamomae (ORCID: https://orcid.org/0000-0001-7115-4822)
Institutions
- Okayama University (JP)
- Toyo Engineering (Japan) (JP)
- Nagoya University (JP)
- Tokushima University (JP)
Publication Details
- Journal
- Reports of Practical Oncology & Radiotherapy
- Published
- 2025-10-03
- DOI
- https://doi.org/10.5603/rpor.106490
- Citations
- 1
- Primary Topic
- Advanced Radiotherapy Techniques
- Type
- article
- Field-Weighted Citation Impact
- 1.88